---
category: listing
circular_id: bbaa7f3b38f69b58
date: '2025-10-07'
description: NSE announces listing of Sheel Biotech Limited equity shares on EMERGE
  SME Platform effective October 08, 2025, with trade-for-trade surveillance segment.
draft: false
guid: https://nsearchives.nseindia.com/content/circulars/CML70685.zip
impact: low
impact_ranking: low
importance_ranking: low
justification: Routine SME IPO listing on EMERGE platform with standard surveillance
  measures
pdf_url: https://nsearchives.nseindia.com/content/circulars/CML70685.zip
processing:
  attempts: 1
  content_hash: 02ab0177fa8c0e5c
  processed_at: '2025-10-07T15:51:55.237126'
  processor_version: '2.0'
  stage: completed
  status: published
published_date: '2025-10-07T00:00:00+05:30'
rss_url: https://nsearchives.nseindia.com/content/circulars/CML70685.zip
severity: low
source: nse
stocks:
- SHEEL
tags:
- listing
- sme-ipo
- emerge-platform
- trade-for-trade
- surveillance
- new-listing
title: Listing of Equity Shares of Sheel Biotech Limited (SME IPO)
---

## Summary

National Stock Exchange announces the listing of equity shares of Sheel Biotech Limited on the EMERGE SME Platform effective October 08, 2025. The security will initially trade in Series 'ST' (Trade for Trade Surveillance Segment with Settlement Type 'W') and subsequently shift to Series 'SM' (Normal Rolling Segment). The company has 20,352,550 equity shares of Rs. 10/- face value with IPO price of Rs. 63/- per share.

## Key Points

- **Symbol**: SHEEL
- **ISIN**: INE0YJV01017
- **Face Value**: Rs. 10/-
- **IPO Price**: Rs. 63/- per share
- **Total Shares**: 20,352,550 equity shares
- **Market Lot**: 2,000 equity shares
- **Trading Series**: ST (Trade for Trade Surveillance Segment - TFTS, Settlement Type 'W')
- **Market Type**: Continuous Market
- **Market Maker Maximum Spread**: Within 10%
- **Pre-open Session**: Applicable for IPO and Other category scrips

## Regulatory Changes

No regulatory changes. This circular follows existing SEBI regulations:
- SEBI circular no. CIR/MRD/DP/01/2012 & CIR/MRD/DP/02/2012 dated January 20, 2012 for pre-open session
- Exchange Circular No. NSE/CMTR/37202 dated March 14, 2018 for continuous market trading

## Compliance Requirements

- Members must identify the security by its designated code (SHEEL)
- Trading must be conducted in specified lot sizes of 2,000 equity shares
- Market Maker minimum quantity: 2,000 equity shares
- The security will be part of pre-open session for IPO category

## Important Dates

- **Effective Date**: October 08, 2025
- **Financial Year**: April 2025 – March 2026

## Impact Assessment

Minimal market impact. This is a standard SME IPO listing on the EMERGE platform. The trade-for-trade surveillance segment (Series ST) indicates enhanced monitoring, which is typical for new SME listings. The security will later transition to normal rolling segment (Series SM) as per standard procedure.

## Company Details

**Registered Office:**
Sheel Biotech Limited
8 Balaji Estates, 2nd Floor, Block-C, Guru Ravidas Marg, Kalkaji
South Delhi, New Delhi - 110019
Tel: +91-8851189801
Email: compliance@sheelbiotech.com
Website: www.sheelbiotech.com

**Company Secretary and Compliance Officer:**
Mr. Anupam Pandey
Tel: +91-8851189801
Email: compliance@sheelbiotech.com

**Registrar & Transfer Agent:**
Skyline Financial Services Private Limited
D-153 A, 1st Floor, Okhla Industrial Area, Phase – I
New Delhi-110020
Tel: +91-11-40450193-97
Email: compliances@skylinerta.com
Contact Person: Mr. Anuj Rana

**Market Maker:**
Mansi Share and Stock Broking Private Limited
B-201, Avirahi Building, Behind Adidas Showroom, S.V. Road
Borivali (West) Mumbai – 400092
Tel: 02240503870
Email: compliance@mansishares.in
Contact Person: Mr. Deep Paresh Shah